Home ETF List About

Portfolio Holdings Detail for ISIN IE00B5BMR087
Stock Name / FundiShares Core S&P 500 UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCSP1(GBX) LSE
ETF TickerSXR8(EUR) F
ETF TickerCSP1.LS(GBX) CXE
ETF TickerCSPX.AS(EUR) CXE
ETF TickerCSPX.LS(USD) CXE
ETF TickerCSSPX.MI(EUR) CXE
ETF TickerCSSPXz(USD) CXE
ETF TickerSXR8.DE(EUR) CXE
ETF TickerCSSPX(EUR) ETF Plus
ETF TickerCSPX(EUR) Euronext Amsterdam
ETF TickerCSP1.L(GBP) LSE

Holdings detail for EW

Stock NameEdwards Lifesciences Corp
TickerEW(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS28176E1082
LEIYA13X31F3V31L8TMPR58

Show aggregate EW holdings

News associated with EW

Edwards Lifesciences (NYSE:EW) Cut to Buy at Wall Street Zen
Edwards Lifesciences (NYSE:EW – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday. A number of other research analysts have also issued reports on the company. Wells Fargo & Company boosted their price objective on Edwards Lifesciences […] - 2025-09-15 05:40:50
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings
Key PointsKen Griffin founded the hedge fund firm Citadel. - 2025-09-09 12:44:48
Top Stock Reports for Apple, Novartis & Charles Schwab
Apple grows Services to 1B+ paid subscribers, while Novartis lifts guidance and Schwab rides higher rates to asset gains. - 2025-09-04 17:29:00
Atria Wealth Solutions Inc. Sells 29,763 Shares of Edwards Lifesciences Corporation (NYSE:EW)
Atria Wealth Solutions Inc. cut its position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 81.7% during the 1st quarter, HoldingsChannel reports. The firm owned 6,662 shares of the medical research company’s stock after selling 29,763 shares during the period. Atria Wealth Solutions Inc.’s holdings in Edwards Lifesciences were worth $483,000 as […] - 2025-08-14 05:04:55
Edwards Lifesciences (NYSE:EW) Raised to Buy at BTIG Research
Edwards Lifesciences (NYSE:EW – Get Free Report) was upgraded by investment analysts at BTIG Research from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $100.00 target price on the medical research company’s stock. BTIG Research’s price target points to a potential […] - 2025-07-31 03:02:52
Edwards Lifesciences (NYSE:EW) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday. Several other research analysts have also weighed in on EW. Wells Fargo & Company lifted their price objective on Edwards Lifesciences from $80.00 to $84.00 and […] - 2025-07-29 02:58:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 13:25:48
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 12:26:28
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 09:49:10
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 08:57:30
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 07:43:41
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 04:16:07
Edwards Lifesciences (NYSE:EW) Price Target Raised to $82.00
Edwards Lifesciences (NYSE:EW – Free Report) had its price objective upped by Truist Financial from $81.00 to $82.00 in a research note published on Friday,Benzinga reports. They currently have a hold rating on the medical research company’s stock. A number of other research firms have also weighed in on EW. Wall Street Zen lowered shares […] - 2025-07-28 04:08:50
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
Edwards Lifesciences (NYSE:EW – Free Report) had its price target increased by JPMorgan Chase & Co. from $80.00 to $85.00 in a report published on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical research company’s stock. Several other brokerages also recently issued reports on EW. Wells Fargo & […] - 2025-07-28 04:08:48
Edwards Lifesciences (NYSE:EW) Price Target Raised to $95.00
Edwards Lifesciences (NYSE:EW – Free Report) had its price target raised by Barclays from $90.00 to $95.00 in a report published on Friday,Benzinga reports. Barclays currently has an overweight rating on the medical research company’s stock. A number of other equities analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their price […] - 2025-07-28 02:46:53
Stifel Nicolaus Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price
Edwards Lifesciences (NYSE:EW – Free Report) had its target price upped by Stifel Nicolaus from $90.00 to $95.00 in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. EW has been the topic of several other research reports. Evercore ISI increased […] - 2025-07-28 02:46:53
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Robert W. Baird Analyst Says
Edwards Lifesciences (NYSE:EW – Free Report) had its target price boosted by Robert W. Baird from $78.00 to $79.00 in a research report report published on Friday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. Other research analysts have also issued reports about the stock. Evercore ISI […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Price Target Raised to $80.00
Edwards Lifesciences (NYSE:EW – Free Report) had its target price lifted by Evercore ISI from $77.00 to $80.00 in a research report report published on Friday,Benzinga reports. The firm currently has an in-line rating on the medical research company’s stock. A number of other brokerages have also issued reports on EW. Argus upgraded shares of […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
Edwards Lifesciences (NYSE:EW – Free Report) had its price objective lifted by Wells Fargo & Company from $80.00 to $84.00 in a report released on Friday morning,Benzinga reports. They currently have an overweight rating on the medical research company’s stock. A number of other research analysts also recently commented on EW. Dbs Bank raised shares […] - 2025-07-28 02:46:49
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price
Edwards Lifesciences (NYSE:EW – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from $85.00 to $94.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. Several other equities analysts have also issued reports on EW. Dbs Bank upgraded […] - 2025-07-28 02:46:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 02:37:03
Solid Corporate Earnings Results Support Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 19:42:53
Solid Corporate Earnings Results Support Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:56:19
Positive Earnings Results Lift Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 14:23:43
Solid Corporate Earnings Results Support Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:18:44
Positive Earnings Results Lift Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 12:39:11
J.W. Cole Advisors Inc. Has $814,000 Stock Holdings in Edwards Lifesciences Corporation (NYSE:EW)
J.W. Cole Advisors Inc. raised its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 220.2% in the 1st quarter, HoldingsChannel reports. The fund owned 11,224 shares of the medical research company’s stock after acquiring an additional 7,719 shares during the period. J.W. Cole Advisors Inc.’s holdings in Edwards Lifesciences were worth $814,000 at […] - 2025-07-25 05:12:50
Sigma Planning Corp Has $294,000 Position in Edwards Lifesciences Corporation (NYSE:EW)
Sigma Planning Corp boosted its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 4.9% in the 1st quarter, HoldingsChannel.com reports. The firm owned 4,055 shares of the medical research company’s stock after acquiring an additional 191 shares during the quarter. Sigma Planning Corp’s holdings in Edwards Lifesciences were worth $294,000 as of its […] - 2025-07-21 05:06:55
Edwards Lifesciences Corporation (NYSE:EW) Position Lowered by Ballentine Partners LLC
Ballentine Partners LLC decreased its stake in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 6.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,109 shares of the medical research company’s stock after selling 375 shares during the period. Ballentine Partners LLC’s holdings […] - 2025-07-16 06:51:32
Alps Advisors Inc. Purchases Shares of 5,090 Edwards Lifesciences Corporation (NYSE:EW)
Alps Advisors Inc. bought a new position in Edwards Lifesciences Corporation (NYSE:EW – Free Report) during the 1st quarter, HoldingsChannel reports. The fund bought 5,090 shares of the medical research company’s stock, valued at approximately $369,000. A number of other hedge funds have also recently added to or reduced their stakes in the stock. Norges […] - 2025-07-16 06:01:07

iShares Core S&P 500 UCITS ETF USD (Acc) EW holdings

DateNumber of EW Shares HeldBase Market Value of EW SharesLocal Market Value of EW SharesChange in EW Shares HeldChange in EW Base ValueCurrent Price per EW Share HeldPrevious Price per EW Share Held
2025-09-18 (Thursday)1,384,556EW holding increased by 82USD 103,218,650EW holding decreased by -893795USD 103,218,65082USD -893,795 USD 74.55 USD 75.2
2025-09-17 (Wednesday)1,384,474EW holding increased by 738USD 104,112,445EW holding increased by 207709USD 104,112,445738USD 207,709 USD 75.2 USD 75.09
2025-09-16 (Tuesday)1,383,736EW holding increased by 328USD 103,904,736EW holding decreased by -1303442USD 103,904,736328USD -1,303,442 USD 75.09 USD 76.05
2025-09-15 (Monday)1,383,408USD 105,208,178USD 105,208,178
2025-09-12 (Friday)1,382,588USD 107,247,351USD 107,247,351
2025-09-11 (Thursday)1,382,342EW holding increased by 410USD 107,836,499EW holding decreased by -341138USD 107,836,499410USD -341,138 USD 78.01 USD 78.28
2025-09-10 (Wednesday)1,381,932USD 108,177,637EW holding decreased by -2100537USD 108,177,6370USD -2,100,537 USD 78.28 USD 79.8
2025-09-09 (Tuesday)1,381,932EW holding increased by 410USD 110,278,174EW holding decreased by -533706USD 110,278,174410USD -533,706 USD 79.8 USD 80.21
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EW by Blackrock for IE00B5BMR087

Show aggregate share trades of EW

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-18BUY82 74.550* 73.46
2025-09-17BUY738 75.200* 73.45
2025-09-16BUY328 75.090* 73.44
2025-09-11BUY410 78.010* 73.41
2025-09-09BUY410 79.800* 73.35
2025-09-08BUY164 80.210* 73.31
2025-09-05BUY1,886 80.940* 73.26
2025-09-04SELL-3,526 80.960* 73.22 Profit of 258,167 on sale
2025-09-02BUY1,722 81.770* 73.17
2025-08-22BUY82 81.830* 73.12
2025-08-21BUY246 81.160* 73.07
2025-08-20BUY328 81.390* 73.02
2025-08-19BUY492 78.930* 72.98
2025-07-31SELL-7,684 79.310* 72.95 Profit of 560,520 on sale
2025-07-30BUY656 81.160* 72.90
2025-07-29BUY82 80.470* 72.85
2025-07-24BUY82 75.800* 72.83
2025-07-23BUY492 76.910* 72.81
2025-07-22BUY738 76.300* 72.79
2025-07-21BUY164 76.560* 72.76
2025-07-18SELL-820 76.490* 72.74 Profit of 59,646 on sale
2025-07-17BUY82 76.180* 72.72
2025-07-16BUY328 76.140* 72.69
2025-07-15SELL-1,245 76.810* 72.67 Profit of 90,472 on sale
2025-07-11SELL-164 78.050* 72.63 Profit of 11,912 on sale
2025-07-10BUY656 78.800* 72.59
2025-07-09BUY656 77.190* 72.56
2025-07-08BUY492 76.390* 72.54
2025-07-07SELL-1,886 76.690* 72.51 Profit of 136,756 on sale
2025-07-02SELL-2,378 77.020* 72.42 Profit of 172,221 on sale
2025-06-30BUY1,394 78.210* 72.38
2025-06-27BUY738 78.210* 72.34
2025-06-25SELL-164 76.970* 72.28 Profit of 11,854 on sale
2025-06-24BUY82 75.850* 72.25
2025-06-23BUY2,132 75.320* 72.23
2025-06-20SELL-246 73.830* 72.22 Profit of 17,766 on sale
2025-06-18SELL-492 73.980* 72.19 Profit of 35,520 on sale
2025-06-13SELL-246 75.150* 72.15 Profit of 17,748 on sale
2025-06-12BUY246 75.890* 72.12
2025-06-11BUY328 75.470* 72.09
2025-06-06SELL-410 77.520* 71.99 Profit of 29,516 on sale
2025-06-05SELL-246 77.770* 71.95 Profit of 17,699 on sale
2025-06-04SELL-328 77.850* 71.90 Profit of 23,583 on sale
2025-06-02BUY1,066 78.100* 71.81
2025-05-30SELL-237 78.220* 71.75 Profit of 17,006 on sale
2025-05-29BUY82 77.730* 71.71
2025-05-28SELL-81 76.660* 71.67 Profit of 5,805 on sale
2025-05-27BUY902 76.220* 71.63
2025-05-23SELL-1,640 74.990* 71.57 Profit of 117,382 on sale
2025-05-22SELL-1,804 74.790* 71.55 Profit of 129,072 on sale
2025-05-21BUY82 76.100* 71.51
2025-05-20BUY656 77.830* 71.46
2025-05-19BUY2,378 78.040* 71.40
2025-05-16BUY2,214 78.000* 71.34
2025-05-15BUY1,804 76.880* 71.29
2025-05-14BUY1,640 76.750* 71.25
2025-05-13SELL-328 75.500* 71.21 Profit of 23,357 on sale
2025-05-12BUY82 74.800* 71.18
2025-05-09BUY246 73.680* 71.15
2025-05-08SELL-2,378 74.630* 71.12 Profit of 169,130 on sale
2025-05-07SELL-1,148 75.040* 71.09 Profit of 81,608 on sale
2025-05-06BUY2,870 74.920* 71.05
2025-05-02BUY246 75.650* 70.97
2025-05-01SELL-410 75.180* 70.93 Profit of 29,081 on sale
2025-04-30BUY246 75.490* 70.89
2025-04-29BUY574 76.280* 70.83
2025-04-28BUY1,224 75.540* 70.79
2025-04-25BUY1,148 76.040* 70.74
2025-04-24BUY328 75.130* 70.69
2025-04-23BUY902 70.460* 70.69
2025-04-22SELL-498 70.600* 70.69 Profit of 35,206 on sale
2025-04-17BUY164 71.530* 70.69
2025-04-16BUY7,784 71.200* 70.69
2025-04-15BUY1,640 70.760* 70.69
2025-04-11BUY2,050 69.400* 70.71
2025-04-10BUY3,362 68.260* 70.74
2025-04-09BUY656 69.900* 70.75
2025-04-08BUY1,722 67.070* 70.79
2025-04-07BUY1,964 69.000* 70.81
2025-04-04SELL-4,920 69.360* 70.83 Profit of 348,462 on sale
2025-04-02BUY574 72.050* 70.81
2025-03-31SELL-2,214 72.480* 70.78 Profit of 156,703 on sale
2025-03-28SELL-1,394 70.910* 70.78 Profit of 98,663 on sale
2025-03-27SELL-410 71.190* 70.77 Profit of 29,016 on sale
2025-03-26BUY738 71.090* 70.77
2025-03-25SELL-984 71.240* 70.76 Profit of 69,630 on sale
2025-03-24BUY574 71.350* 70.75
2025-03-21BUY984 70.460* 70.76
2025-03-19BUY152 70.900* 70.75
2025-03-18SELL-1,476 70.340* 70.76 Profit of 104,441 on sale
2025-03-17BUY1,558 70.630* 70.76
2025-03-14BUY1,394 69.290* 70.78
2025-03-13BUY6,876 67.950* 70.82
2025-03-12BUY3,280 68.510* 70.85
2025-03-11BUY1,312 68.390* 70.89
2025-03-07BUY778 70.330* 70.93
2025-03-06SELL-738 71.800* 70.92 Profit of 52,339 on sale
2025-03-05BUY2,554 72.850* 70.89
2025-03-04BUY492 71.380* 70.88
2025-03-03BUY2,214 71.390* 70.88
2025-02-28SELL-574 71.620* 70.86 Profit of 40,675 on sale
2025-02-27BUY82 71.400* 70.85
2025-02-26SELL-164 71.960* 70.84 Profit of 11,617 on sale
2025-02-25BUY1,558 71.450* 70.83
2025-02-21BUY1,148 73.300* 70.75
2025-02-20BUY656 74.710* 70.68
2025-02-19BUY164 74.670* 70.60
2025-02-18BUY410 75.670* 70.51
2025-02-13BUY1,394 76.000* 70.18
2025-02-12BUY492 75.820* 70.07
2025-02-11SELL-164 70.910* 70.05 Profit of 11,488 on sale
2025-02-07SELL-656 70.350* 70.02 Profit of 45,934 on sale
2025-02-06BUY328 70.990* 70.00
2025-02-04BUY2,870 71.330* 69.92
2025-02-03BUY1,066 71.380* 69.89
2025-01-31BUY246 72.450* 69.83
2025-01-30BUY164 73.220* 69.75
2025-01-29BUY1,558 71.130* 69.71
2025-01-28BUY738 72.560* 69.64
2025-01-27BUY1,148 69.200* 69.65
2025-01-24BUY738 68.990* 69.67
2025-01-23BUY2,132 68.930* 69.69
2025-01-22BUY1,394 69.040* 69.71
2025-01-06BUY820 73.540* 69.59
2024-12-10BUY588 73.390* 69.48
2024-12-09BUY672 70.900* 69.43
2024-12-06BUY1,008 71.530* 69.37
2024-12-05BUY252 72.430* 69.26
2024-12-04BUY924 74.200* 69.09
2024-12-03BUY2,964 70.200* 69.05
2024-12-02BUY247 70.530* 69.00
2024-11-29BUY1,909 71.350* 68.91
2024-11-27BUY2,241 72.070* 68.65
2024-11-26BUY4,814 71.550* 68.52
2024-11-25BUY4,980 71.270* 68.39
2024-11-22BUY5,880 70.480* 68.30
2024-11-21BUY924 70.380* 68.19
2024-11-20BUY840 69.540* 68.12
2024-11-19BUY756 70.200* 68.00
2024-11-18BUY6,732 69.890* 67.89
2024-11-12BUY2,324 65.810* 68.02
2024-11-11BUY1,577 66.700* 68.11
2024-11-08BUY1,190 66.230* 68.25
2024-11-07BUY7,387 65.840* 68.43
2024-11-06BUY2,241 65.750* 68.66
2024-11-05BUY3,306 66.690* 68.83
2024-11-04BUY581 66.470* 69.07
2024-11-01BUY1,328 67.540* 69.24
2024-10-31BUY336 67.010* 69.52
2024-10-30BUY834 68.630* 69.65
2024-10-29BUY2,016 69.370* 69.69
2024-10-28SELL-588 68.520* 69.93 Profit of 41,116 on sale
2024-10-25BUY1,008 69.380* 70.06
2024-10-24BUY672 70.350* 69.97
2024-10-23BUY840 70.610* 69.65
2024-10-22BUY2,165 69.240* 70.05
2024-10-21BUY2,352 70.050* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EW

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19406,40201,881,72721.6%
2025-09-18684,5201,1773,487,98119.6%
2025-09-17484,3222101,603,06530.2%
2025-09-16811,9538562,055,93739.5%
2025-09-15611,0121041,391,88243.9%
2025-09-12982,9281,1002,234,22744.0%
2025-09-11514,2348281,919,00926.8%
2025-09-10669,7051491,567,94142.7%
2025-09-09441,4930925,37547.7%
2025-09-08632,5876721,251,93950.5%
2025-09-05334,037300934,00635.8%
2025-09-04380,3180871,93143.6%
2025-09-03701,9434591,170,96659.9%
2025-09-02397,396531,208,87232.9%
2025-08-29397,628800844,31847.1%
2025-08-28604,08741,056,65357.2%
2025-08-27493,608822875,88656.4%
2025-08-26480,2680868,21355.3%
2025-08-25796,55601,181,25867.4%
2025-08-22552,73911,011,67854.6%
2025-08-21873,0447981,597,74254.6%
2025-08-20847,84738,6991,560,10554.3%
2025-08-19613,349331,256,57748.8%
2025-08-18668,7194391,642,75940.7%
2025-08-15369,455513826,72344.7%
2025-08-14514,2026,112864,59359.5%
2025-08-13567,8572991,347,26442.1%
2025-08-12547,77312,3161,428,27738.4%
2025-08-11487,82301,152,63042.3%
2025-08-08661,697201,224,45854.0%
2025-08-07669,9319821,297,46951.6%
2025-08-06880,0284131,551,65956.7%
2025-08-05661,93381,592,64941.6%
2025-08-04572,1652681,310,04443.7%
2025-08-01678,0285,6001,308,86351.8%
2025-07-31831,4012491,817,97545.7%
2025-07-301,305,0166932,481,80852.6%
2025-07-291,129,154582,399,22347.1%
2025-07-28684,1012,1112,276,89230.0%
2025-07-251,669,7529206,616,25925.2%
2025-07-24455,59302,607,89817.5%
2025-07-23444,64501,978,11022.5%
2025-07-22447,8835112,702,92516.6%
2025-07-21568,293271,249,72745.5%
2025-07-18590,448592,118,40227.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.